On the Record · Emergent BioSolutions
Emergent BioSolutions competitors, on the record
The companies Emergent BioSolutions itself names as competitors in its annual reports, 2023 to 2025, each with the sentence it appears in and the filing it came from.
Who Emergent BioSolutions names
| Company | Named in |
|---|---|
| Adamis Pharmaceuticals Corporation | 2025 |
| Amneal Pharmaceuticals, Inc. | 2025 |
| Harm Reduction Therapeutics | 2025 |
| KM Biologics | 2025 |
| Padagis LLC | 2025 |
| Summit Biosciences Inc. | 2025 |
| Teleflex Medical Inc. | 2025 |
| ZMI Pharma, Inc. | 2025 |
In its own words
Adamis Pharmaceuticals Corporation, Harm Reduction Therapeutics, Summit Biosciences Inc., Teleflex Medical Inc., ZMI Pharma, Inc.
Word for word“NARCAN ® Nasal Spray also faces branded competition from prescription products, such as Zimhi™ (naloxone), a branded injectable product developed by Adamis Pharmaceuticals Corporation, Rextovy TM, (naloxone HCL nasal spray 4 mg), a branded product marketed by ZMI Pharma, Inc., Teleflex Medical Inc.'s Intranasal Mucosal Atomization Device, and Rezenopy ® (naloxone HCL nasal spray 10mg), a branded product manufactured by Summit Biosciences Inc., as well as OTC products, such as RiVive TM (naloxene HCl nasal spray 3mg), a branded product developed by Harm Reduction Therapeutics.” 10-K for 2025
Amneal Pharmaceuticals, Inc., Padagis LLC
Word for word“NARCAN ® Nasal Spray also faces generic competition from Padagis LLC (“Padagis”) and Amneal Pharmaceuticals, Inc. (“Amneal”).” 10-K for 2025
KM Biologics
Word for word“ACAM2000 ® vaccine also faces competition from KM Biologics LC16m8 vaccine, which is approved in Japan for smallpox and mpox.” 10-K for 2025
Read from Emergent BioSolutions’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-27. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.